User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Cardiovascular effects of beta 3-adrenoceptor stimulation in perinephritic hypertension.

Primary tabs

Donckier, Julian [UCL] Massart, Pascale [UCL] Van Mechelen, Henri [UCL] Heyndrickx, Guy [UCL] Gauthier, C Balligand, Jean-Luc [UCL]

BACKGROUND: A new beta 3-adrenoceptor (beta3-AR) has been shown to mediate peripheral vasodilation. This study was conducted to evaluate effects of the beta3-AR agonist, SR58611 in normal and hypertensive dogs. MATERIALS AND METHODS: In protocol 1, SR58611 was infused in normal dogs after placebo, after beta1/beta2 blockade with nadolol, after beta1/beta2/beta3 blockade with bupranolol and after combined autonomic blockade (CAB). In protocol 2, perinephritic hypertension was produced in dogs, which received SR58611 at 3 and 6 weeks of hypertension. Effects of SR58611 were evaluated at 7 weeks of hypertension after CAB. RESULTS: In normal dogs, SR58611 produced a dose-dependent decrease in mean aortic pressure (AOP) (from 116 +/- 19 to 100 +/- 19 mmHg, - 14%; P < 0.05) that was accompanied by baroreflex activation (heart rate increased by 70%; P < 0.01). This hypotensive effect resulting from peripheral vasodilation persisted after nadolol or CAB while baroreflex activation was blunted or abolished. A biphasic response of cardiac output, characterized by a rise and a decline (P < 0.05) reflected a reduction in after- and pre-load. After CAB, SR58611 did not modify cardiac contractility. SR58611 stimulated lipolysis as reflected by a 4-fold increase in blood free fatty acids (FFA) (P < 0.0005). Under CAB, the rise of FFA was reduced (P < 0.01). In hypertensive dogs, SR58611 produced a dose-dependent decrease in mean AOP (from 168 +/- 32 to 125 +/- 35 mmHg; - 26%, P < 0.0001), that was greater than in normal dogs (P < 0.05). Reflex-mediated tachycardia also occurred but at higher blood pressure values. Blood FFA rose similarly (P < 0.0001). Under CAB, heart rate remained unchanged but SR58611 still induced a decrease (P < 0.0001) in mean AOP concomitantly with a rise of (dP/dt)/DP40 (P < 0.005), an effect not observed in normal dogs. CONCLUSIONS: Beta3-AR stimulation exerts hypotensive effects, increases cardiac contractility and stimulates lipolysis in hypertensive dogs.

  1. Arch JR, Nature (Lond, 309, 163 (1984)
  2. Langin Dominique, Portillo Maria P., Saulnier-Blache Jean-Sébastien, Lafontan Max, Coexistence of three β-adrenoceptor subtypes in white fat cells of various mammalian species, 10.1016/0014-2999(91)90492-9
  3. van der Vliet A, J Pharmacol Exp Ther, 255, 218 (1990)
  4. Tamaoki J, J Appl Physiol, 74, 297 (1993)
  5. Emorine LJ, Science, 245, 118 (1989)
  6. Granneman JG, Mol Pharmacol, 40, 895 (1991)
  7. Berlan M, J Pharmacol Exp Therap, 268, 1444 (1994)
  8. Shen Y-T, J Pharmacol Exp Therap, 268, 466 (1994)
  9. Gauthier C, J Clin Invest, 102, 1377 (1998)
  10. Gauthier C, J Pharmacol Exp Therap, 290, 687 (1999)
  11. Shen Y-T, J Pharmacol Exp Therap, 278, 1435 (1996)
  12. Kaumann Alberto J., Four β-adrenoceptor subtypes in the mammalian heart, 10.1016/s0165-6147(96)01033-4
  13. Trochu J-N, Br J Pharmacol, 128, 69 (1999)
  14. Danet S., Richard F., Montaye M., Beauchant S., Lemaire B., Graux C., Cottel D., Marecaux N., Amouyel P., Unhealthy Effects of Atmospheric Temperature and Pressure on the Occurrence of Myocardial Infarction and Coronary Deaths : A 10-Year Survey: The Lille-World Health Organization MONICA Project (Monitoring Trends and Determinants in Cardiovascular Disease), 10.1161/01.cir.100.1.e1
  15. Donckier J. E., Massart P.-E., Hodeige D., Van Mechelen H., Clozel J.-P., Laloux O., Ketelslegers J.-M., Charlier A. A., Heyndrickx G. R., Additional Hypotensive Effect of Endothelin-1 Receptor Antagonism in Hypertensive Dogs Under Angiotensin-Converting Enzyme Inhibition, 10.1161/01.cir.96.4.1250
  16. Donckier J., Stoleru L., Hayashida W., Van Mechelen H., Selvais P., Galanti L., Clozel J.-P., Ketelslegers J.-M., Pouleur H., Role of Endogenous Endothelin-1 in Experimental Renal Hypertension in Dogs, 10.1161/01.cir.92.1.106
  17. PAGE IRVINE H., THE PRODUCTION OF PERSISTENT ARTERIAL HYPERTENSION BY CELLOPHANE PERINEPHRITIS, 10.1001/jama.1939.02800480032008
  18. National Institutes of Health., NIH Guide (1996)
  19. Sansdrap J, Computers in Cardiology., 433 (1981)
  20. Donckier J. E., Hanet C., Berbinschi A., Galanti L., Robert A., Van Mechelen H., Pouleur H., Ketelslegers J. M., Cardiovascular and endocrine effects of endothelin-1 at pathophysiological and pharmacological plasma concentrations in conscious dogs, 10.1161/01.cir.84.6.2476
  21. Heyndrickx GR, Am J Physiol, 254, H817 (1988)
  22. Frederiksen JW, Am J Physiol, 235, H701 (1978)
  23. Weiss JL, J Clin Invest, 58, 751 (1976)
  24. Galitzky J, Am J Physiol, 264, E403 (1993)
  25. Galitzky J, J Pharmacol Exp Ther, 266, 358 (1993)
  26. Pietri-Rouxel F, Eur J Biochem, 230, 350 (1995)
  27. Tavernier G, J Pharmacol Exp Therap, 263, 1083 (1992)
  28. Montastruc JL, Fundam Clin Pharmacol, 13, 180 (1999)
  29. Grassi G., Cattaneo B. M., Seravalle G., Lanfranchi A., Mancia G., Baroreflex Control of Sympathetic Nerve Activity in Essential and Secondary Hypertension, 10.1161/01.hyp.31.1.68
  30. Massart Pierre-Emmanuel, Hodeige Dominique G., Van Mechelen Henri, Charlier André A., Ketelslegers Jean-Marie, Heyndrickx Guy R., Donckier Julian E., Angiotensin II and endothelin-1 receptor antagonists have cumulative hypotensive effects in canine Page hypertension : , 10.1097/00004872-199816060-00015
  31. Brawley Lee, Shaw Angus M, MacDonald Allan, Role of endothelium/nitric oxide in atypical β-adrenoceptor-mediated relaxation in rat isolated aorta, 10.1016/s0014-2999(00)00319-8
  32. Dessy Ch, Circulation, 102, II (2000)
Bibliographic reference Donckier, Julian ; Massart, Pascale ; Van Mechelen, Henri ; Heyndrickx, Guy ; Gauthier, C ; et. al. Cardiovascular effects of beta 3-adrenoceptor stimulation in perinephritic hypertension.. In: European journal of clinical investigation, Vol. 31, no. 8, p. 681-9 (2001)
Permanent URL http://hdl.handle.net/2078.1/22342